10-Q: Charlotte's Web Reports Q2 2024 Results: Revenue Declines Amid Strategic Shifts

Charlotte's Web experienced a significant revenue decrease in the second quarter of 2024, alongside strategic changes including price reductions and brand consolidation.

Summary

• Charlotte's Web reported a 23.2% decrease in total revenue for the three months ended June 30, 2024, compared to the same period in 2023, with revenue totaling $12.289 million.
• Direct-to-consumer (DTC) revenue fell by 27.1% year-over-year, while business-to-business (B2B) revenue decreased by 16.6%.
• The company's cost of goods sold increased by 36.9%, primarily due to a $3.7 million increase in inventory provisions.
• Gross profit decreased by 71.0%, with a gross margin of 21.0% compared to 55.7% in the prior year.
• Selling, general, and administrative expenses decreased by 25.0%, due to reduced personnel, share-based compensation, and consulting costs.
• The company reported a net loss of $11.057 million for the quarter, compared to a net income of $2.844 million in the same period last year.
• For the six months ended June 30, 2024, total revenue was $24.413 million, a 26.1% decrease compared to the same period in 2023.
• The net loss for the first six months of 2024 was $20.691 million, compared to a net loss of $67 thousand in the first six months of 2023.
• The company's cash and cash equivalents were $32.531 million as of June 30, 2024, down from $47.820 million at the end of 2023.

Sentiment

Score: 3

Explanation: The document indicates a significant downturn in financial performance, with decreased revenue, increased costs, and a net loss. While there are some positive strategic shifts, the overall tone is negative due to the poor financial results.

Positives

• Selling, general, and administrative expenses decreased by 25.0% year-over-year, indicating successful cost-cutting measures.
• The company launched new products, including CBN 'Stay Asleep' gummies, demonstrating innovation.
• The company added Walmart as a retail partner, expanding its distribution network.
• The company consolidated its brands under the Charlotte's Web name, which may improve brand recognition.
• The company reduced prices on its leading CBD oils, which may improve consumer accessibility and sales volume.
• The company transitioned to a new e-commerce platform, which may improve customer experience and sales.

Negatives

• Total revenue decreased by 23.2% in Q2 2024 compared to Q2 2023, indicating a significant decline in sales.
• DTC revenue decreased by 27.1% year-over-year, suggesting challenges in online sales.
• B2B revenue decreased by 16.6% year-over-year, indicating reduced retail shelf space and consumer spending.
• Cost of goods sold increased by 36.9%, primarily due to a $3.7 million increase in inventory provisions.
• Gross profit decreased by 71.0%, resulting in a significantly lower gross margin of 21.0%.
• The company reported a net loss of $11.057 million for the quarter, a significant downturn from the prior year's net income.
• Cash and cash equivalents decreased from $47.820 million at the end of 2023 to $32.531 million as of June 30, 2024.

Risks

• The company faces challenges in maintaining revenue growth due to decreased online traffic and reduced retail shelf space.
• The increase in inventory provisions indicates potential issues with inventory management and market demand.
• The company's financial performance is significantly impacted by changes in fair value of financial instruments, which are subject to market volatility.
• New state regulations may impact the company's ability to sell certain products as currently formulated or packaged.
• The company's ability to fund its operations depends on future operating performance and may require additional capital raising.
• The company's ability to raise additional funds is dependent on market conditions and investor sentiment.

Future Outlook

The company expects selling, general, and administrative expenses to be significantly lower compared to 2023 due to expense reduction actions. The company plans to meet liquidity requirements through cash on hand and operations, and may consider fundraising opportunities.

Management Comments

• The company has refreshed its mission to 'Unearth the Science of Nature to Revolutionize Wellness'.
• The company is evolving its wellness offerings to strengthen its core leadership in CBD and extend beyond CBD to include a broader range of botanical wellness solutions.
• The company is working to capitalize on the rapidly emerging botanical wellness products industry by driving customer acquisition and retention, as well as accelerating retail expansion.
• The company may consider expanding its product line beyond Hemp-based products should the science and the company's founding principles support such expansion.

Industry Context

The company is operating in a rapidly evolving botanical wellness market, facing increased competition and regulatory changes. The company's strategic shifts, including price reductions and brand consolidation, reflect an attempt to adapt to these market dynamics. The company's focus on science-backed products and expansion into minor cannabinoids like CBN aligns with current industry trends.

Comparison to Industry Standards

• The company's revenue decline of 23.2% in Q2 2024 is worse than the average performance of many established companies in the consumer packaged goods sector, which typically experience more stable sales.
• The gross margin of 21.0% is significantly lower than the industry average for companies in the health and wellness sector, which often see margins above 40%.
• The increase in inventory provisions suggests potential issues with inventory management, which is a common challenge for companies in the agricultural and manufacturing sectors.
• The company's strategic shift to reduce prices on its leading CBD oils is a common tactic used by companies to increase market share, but it may impact profitability if not managed carefully.
• The company's investment in R&D and expansion into new product categories like CBN is consistent with the industry trend of innovation and diversification.

Management Changes

Legal Proceedings

• The company is not a party to any material pending legal proceedings, other than ordinary routine litigation incidental to the business.

Related Party Transactions

• The company has a secured promissory note with one of its founders, which has been extended to November 13, 2024.
• The company has a purchase option agreement with Stanley Brothers USA, where certain founders of the company are majority shareholders.
• The company jointly formed DeFloria LLC with AJNA and BAT, where a co-founder of Charlotte's Web is a co-founder of AJNA.
• The company has a note receivable with DeFloria for the sale of lab equipment.
• The company has a master services agreement with DeFloria, where the company provides services and is compensated.
• The company has a consulting agreement with Jared Stanley, a co-founder and former executive of the company.

Stakeholder Impact

• Shareholders are negatively impacted by the decreased revenue, increased costs, and net loss.
• Employees may be impacted by cost-cutting measures, including potential reductions in personnel.
• Customers may benefit from the price reductions on CBD oils and new product launches.
• Suppliers may be impacted by changes in the company's production and sourcing strategies.
• Creditors may be concerned about the company's decreased cash and increased losses.

Next Steps

• The company will continue to assess the business and financial impacts of new state regulations.
• The company will continue to invest in R&D efforts to identify new product opportunities.
• The company will work to capitalize on the rapidly emerging botanical wellness products industry by driving customer acquisition and retention, as well as accelerating retail expansion.
• The company may consider expanding its product line beyond Hemp-based products should the science and the company's founding principles support such expansion.

Key Dates

Keywords

CBD, hemp, cannabinoids, revenue, gross profit, net loss, e-commerce, retail, inventory, financial results, CBN, botanical wellness